Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Safety, and Efficacy of EUS-guided Thermal Radiofrequency Ablation in the Treatment of Gastrointestinal Stromal Tumors

NCT05453292 is registered in ClinicalTrials.gov with Instituto Ecuatoriano de Enfermedades Digestivas as lead sponsor.

NCT NCT05453292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05453292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Safety, and Efficacy of EUS-guided Thermal Radiofrequency Ablation in the Treatment of Gastrointestinal Stromal Tumors
Lead sponsor
Instituto Ecuatoriano de Enfermedades Digestivas
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2024
Completion date
September 15, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal stromal tumor (gist)